Community Research and Development Information Service - CORDIS

From symptom relief to disease modifying allergy treatment with Glycan-Allergen Immunotherapy

From 2017-03-01 to 2017-08-31, ongoing project

Project details

Total cost:

EUR 71 429

EU contribution:

EUR 50 000

Coordinated in:

Netherlands

Call for proposal:

H2020-SMEINST-1-2016-2017See other projects for this call

Funding scheme:

SME-1 - SME instrument phase 1

Objective

Coordinator

DC4U
Netherlands

EU contribution: EUR 50 000


Albrechtlaan 14a
1404AK Bussum
Netherlands
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
Record Number: 208141 / Last updated on: 2017-02-07
Follow us on: RSS Facebook Twitter YouTube Managed by the EU Publications Office Top